HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

NCT00703872 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Oral HDV-Interferon + ribavarin
DRUG: Injectable HDV-Interferon + ribavarin

Sponsor

Hepasome Pharmaceuticals